Correlation Between Navidea Biopharmaceutica and Aravive

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and Aravive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and Aravive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Navidea Biopharmaceuticals and Aravive, you can compare the effects of market volatilities on Navidea Biopharmaceutica and Aravive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of Aravive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and Aravive.

Diversification Opportunities for Navidea Biopharmaceutica and Aravive

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Navidea and Aravive is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and Aravive in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aravive and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with Aravive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aravive has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and Aravive go up and down completely randomly.

Pair Corralation between Navidea Biopharmaceutica and Aravive

Given the investment horizon of 90 days Navidea Biopharmaceuticals is expected to generate 0.98 times more return on investment than Aravive. However, Navidea Biopharmaceuticals is 1.02 times less risky than Aravive. It trades about -0.5 of its potential returns per unit of risk. Aravive is currently generating about -0.83 per unit of risk. If you would invest  11.00  in Navidea Biopharmaceuticals on September 12, 2024 and sell it today you would lose (1.04) from holding Navidea Biopharmaceuticals or give up 9.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Navidea Biopharmaceuticals  vs.  Aravive

 Performance 
       Timeline  
Navidea Biopharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Navidea Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Navidea Biopharmaceutica is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Aravive 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aravive has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Aravive is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Navidea Biopharmaceutica and Aravive Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Navidea Biopharmaceutica and Aravive

The main advantage of trading using opposite Navidea Biopharmaceutica and Aravive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, Aravive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aravive will offset losses from the drop in Aravive's long position.
The idea behind Navidea Biopharmaceuticals and Aravive pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Managers
Screen money managers from public funds and ETFs managed around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios